Author Question: Participants can be classified as at risk or at minimal risk. What is the difference? What will ... (Read 88 times)

LCritchfi

  • Hero Member
  • *****
  • Posts: 519
Participants can be classified as at risk or at minimal risk. What is the difference?
 
  What will be an ideal response?

Question 2

When is it acceptable to use deception in a research study?
 
  What will be an ideal response?



Ddddd

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

Participants at minimal risk are placed under no more physical or emotional risk than would be encountered in daily life or in routine physical or psychological examinations or tests. Participants at risk are those at risk for physical or emotional harm or those whose privacy is compromisedin other words, the results from the study are not completely confidential.

Answer to Question 2

Psychologists only use deception in a research study when they have determined that the use of deceptive techniques is justified by the study's significant prospective scientific, educational, or applied value and that effective nondeceptive alternative procedures are not feasible.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

Nearly all drugs pass into human breast milk. How often a drug is taken influences the amount of drug that will pass into the milk. Medications taken 30 to 60 minutes before breastfeeding are likely to be at peak blood levels when the baby is nursing.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library